Akari Therapeutics Announces Positive Preliminary Results from First PNH Patient Treated With Coversin Biotech Investing
PharmaCyte Biotech Finalizes Design of Pancreatic Cancer Clinical Trial and Identifies Trial Sites under Consideration Biotech Investing
European Medicines Agency Grants Accelerated Assessment of Marketing Authorization Application for Xilonix™, XBiotech’s True Human™ Therapeutic Antibody Treatment for Advanced Colorectal Cancer Biotech Investing
Lipoprotein(a) Foundation Highlights ACC Research Reinforcing the Significance of Lp(a) as a Genetic Risk Factor for Cardiovascular Disease Biotech Investing
New Clinical and Pre-Clinical Data Presented at American College of Cardiology Meeting on the Effect of EPA Therapy in Statin-Treated Patients and on Endothelial Function in Exploratory Studies Biotech Investing
Akari Therapeutics Announces Positive Preliminary Results from First PNH Patient Treated With Coversin Biotech Investing
Amicus Therapeutics Receives Positive CHMP Opinion for Approval of Migalastat in Patients with Fabry Disease in European Union Biotech Investing
FLIXABI®, an Infliximab Biosimilar Candidate Referencing Remicade®, Receives Positive CHMP Biotech Investing
Vaxil Receives Canadian Notice of Patent Allowance for Its Lead Immunotherapy Platform, Including Its ImMucin(TM) Cancer Vaccine Biotech Investing
Cellceutix Successfully Completes In Vitro Study in Support of Planned Phase 2 Trial of Kevetrin for Ovarian Cancer Biotech Investing
